Liver Model Articles & Analysis
7 news found
Gastrointestinal (GI) and liver diseases are complex conditions that can greatly impact a person's quality of life. ...
Through this partnership, we aim to provide researchers with the tools and expertise needed to accelerate their research efforts in developing liver models for drug discovery, accurate cancer models for precision medicine, and exploring the potential of combining light and extrusion bioprinting modalities to advance tissue ...
ByCELLINK
The milestone acknowledges development of a human tissue-based model of an undisclosed rare liver disease using the company’s REVEAL-Tx™ platform. ...
Podium presentation highlights significant transduction and transgene expression in pharmacokinetic studies in mice, non-human primates and a humanized liver model Poster presentation focuses on pharmacology, toxicology and safety studies Poster presentation focuses on the development of a novel transduction assay to evaluate in-vitro relative Infectivity ...
“External partnerships are a key part of Takeda’s drug discovery model and our collaboration with HemoShear has been important for advancing our liver disease portfolio,” said Gareth Hicks, PhD, vice president & head of the Gastrointestinal Drug Discovery Unit at Takeda. ...
Watkins, international drug safety expert and director of the Hamner-University of North Carolina Institute for Drug Safety Sciences, has received an Agilent Thought Leader Award in recognition of his ongoing work developing integrated methods to predict drug-induced liver injury (DILI). This award continues Agilent's support of the research Hamner scientists are conducting on ...
To answer this question, they created seven different mouse models. The models focused on liver, kidney and lung regeneration; wound healing; corneal vascularization; and retinal vascularization. ...